Diabetes Mellitus and Parkinson’s Disease
Objective: To investigate the association of type 2 diabetes mellitus (DM) with markers of Parkinson’s pathology in patients with early de novo Parkinson’s disease (PD).…Self-rated burden grading of nonmotor symptoms identifies landmarks and subtypes of Parkinson’s disease: first report from a Moscow-Madrid-London collaboration
Objective: To describe clinical and imaging biomarkers of nonmotor symptoms burden (NMSB) as defined by NMS questionnaire (NMSQ) scores in a prospective international cohort study…Long-term Effects of Subthalamic Nucleus Deep Brain Stimulation on Quality of Life, Non-motor and Motor Symptoms
Objective: To study the long-term effects of bilateral subthalamic deep brain stimulation (STN-DBS) on Quality of Life (QoL), motor, non-motor symptoms (NMS) in patients with…Use of pimavanserin in patients with Parkinson’s disease psychosis: Subgroup analysis of efficacy and safety in patients with and without cognitive impairment
Objective: A planned subgroup analysis of a phase 3 study was performed to evaluate the efficacy and safety of pimavanserin (PIM) in Parkinson’s disease psychosis…Clinical correlates of severe somnolence in Parkinson’s disease: results from an international naturalistic non-motor symptoms cohort
Objective: To compare patients with mild and severe daytime somnolence using cut-off values from item 15 of the Parkinson’s disease (PD) sleep scale (PDSS). Background:…Motor performance measured with the UPDRS in PD patientswith varying degrees of smell loss
Objective: To establish whether there is a possible link between the motor symptoms, which includes RBD in PD patients in this study, who have mild/moderate…Non-motor symptoms in a cross section of PD patients with varying degrees of smell loss
Objective: To establish whether patients with PD who have mild/moderate microsmia, severe microsmia or anosmia (as measured by the University of Pennsylvania Smell Identification Test…Parkinson’s Disease and Urogenital Dysfunction
Objective: The aim of this study is to identify the involvement of urogenital functions in PD. Background: Urogenital dysfunction could occur in neurological diseases due to central…Are patients with Parkinson’s disease who have either mild to moderate microsmia, severe microsmia or anosmia clinically different?
Objective: To investigate the prevalence of loss sense of smell and its possible link with the natural history of PD. Background: Non-motor symptoms (NMS) in…Association of Metabolic Syndrome and Change in Unified Parkinson Disease Rating Scale Scores
Objective: To explore the association between metabolic syndrome and Unified Parkinson Disease Rating Scale (UPDRS) scores. Background: While studies suggest that metabolic syndrome increases the…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.